1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...